International Standard ISO 10993-23 | |
Biological evaluation of medical devices — Part 23: Tests for irritation Évaluation biologique des dispositifs médicaux — Partie 23: Essais d'irritation Reference number ISO 10993-23:2021(en) | First edition 2021-01
© ISO 2021
|
[1] | ISO 9394:2012, Ophthalmic optics — Contact lenses and contact lens care products — Determination of biocompatibility by ocular study with rabbit eyes | |
[2] | Agner T. Noninvasive measuring methods for the investigation of irritant patch test reactions. A study of patients with hand eczema, atopic dermatitis and controls. Acta Derm. Venereol. Suppl. (Stockh.). 1992, 173 pp. 1–26 | |
[3] | Alépée N., Tornier C., Robert C., Amsellem C., Roux M.-H., Doucet O., & et al A catch-up validation study on reconstructed human epidermis (SkinEthicTM RHE) for full replacement of the Draize skin irritation test. Toxicol. In Vitro. 2010, 24 pp. 257–266 | |
[4] | Casas J.W., Lewerenz G.M., Rankin E.A., Willoughby J.A., Blakeman L.C., McKim J.M., & et al In Vitro Human Skin Irritation Test for Evaluation of Medical Device Extracts. Toxicol. In Vitro. 2013, 27 pp. 2175–2183 | |
[5] | Coleman K.P., Grailer T.P., McNamara L.R., Rollins B.L., Christiano N.J., Kandárová H., & et al Preparation of irritant polymer samples for an in vitro round robin study. Toxicol. In Vitro. 2018, 50 pp. 401–406. | |
[6] | De Jong W.H., Hoffmann S., Lee M., Kandárová H., Pellevoisin C., Haishima Y., & et al Round robin study to evaluate the reconstructed human epidermis (RhE) model as an in vitro skin irritation test for detection of irritant activity in medical device extracts. Toxicol. In Vitro. 2018, 50 pp. 439–449. | |
[7] | Draize J.H., Woodand G., & Calvery H.O. (1944). Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J. Pharmacol. Exp. Ther. 1944, 82 pp. 337–390 | |
[8] | Draize J.H. Appraisal of the safety of chemicals in foods, drugs, and cosmetics, Austin, Texas, Association of food and drug officials of the United States, Texas State Department of Health, 1959 | |
[9] | Faller C., Bracher M., Dami N., & Roguet R. Predictive ability of reconstructed human epidermis equivalents for the assessment of skin irritation of cosmetics. Toxicol. In Vitro. 2002, 16 pp. 557–572 | |
[10] | Hagi-Pavli E., Williams D.M., Rowland J.L., Thornhill M., & Cruchley A.T. Characterizing the immunological effects of oral healthcare ingredients using an in vitro reconstructed human epithelial model. Food Chem. Toxicol. 2014, 74 pp. 139–148 | |
[11] | Horita K., Tomita C., Yasoshima M., & Matsunaga K. Optimal evaluation time point for patch testing to predict skin irritation of commercial topical drugs. J. Dermatol. 2015, 42 pp. 851–860. | |
[12] | Kandárová H., Hayden P., Klausner M., Kubilus J., Kearney P., & Sheasgreen J. (2009): In Vitro Skin Irritation Test: Improving the Sensitivity of the EpiDerm Skin Irritation Test Protocol. ATLA 37, 671–669, 2009 | |
[13] | Kandarova H., Willoughby J.A., De Jong W.H., Letasiova S., Milasova T., Bachelor M.A., & et al Pre-validation of an in vitro skin irritation test for medical devices using the reconstructed human tissue model EpiDerm™ Toxicol. In Vitro. 2018, 50 pp. 407–417. | |
[14] | Kandárová H., Bendova H., Letasiova S., Coleman K.P., De Jong W.H., & Jírova D. Evaluation of the medical devices benchmark materials in the controlled human patch testing and in the RhE in vitro skin irritation protocol. Toxicol. In Vitro. 2018, 50 pp. 433–438 | |
[15] | Lee C.H., & Maibach H.I. The sodium lauryl sulfate model: an overview. Contact Dermat. 1995, 33 pp. 1–7 | |
[16] | Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 1983, 65 pp. 55–62 | |
[17] | Olsen D.S., Lee M., & Turley A.P. Assessment of test method variables for in vitro skin irritation testing of medical device extracts. Toxicol. In Vitro. 2018, 50 pp. 426–432. | |
[18] | Pellevoisin C., Tornier C., Bremond C., Rollins B., Briotet D., Turley A., & et al Skin irritation of medical devices: In vitro assay with EPISKIN reconstructed human epidermis (RHE). Toxicol. Lett. 2016, 258 (S63) p. viii | |
[19] | Pellevoisin C., Videau C., Briotet D., Grégoire C., Tornier C., Alonso A., & et al SkinEthic™ RHE for in vitro evaluation of skin irritation of medical device extracts. Toxicol. In Vitro. 2018, 50 pp. 419–425 | |
[20] | SOP of in vitro skin irritation of medical devices extracts with SkinEthic™ RHE. EPISKIN SA, Lyon (France), Available at https://www.episkin.com/~/media/Files/SOP-SkinEthic-RHE-Irritation-Medical-devices, 2018 | |
[21] | In Vitro EpiDerm™ Skin Irritation Test (EPI-200-SIT). Protocol For use with MatTek Corporation’s Reconstructed Human Epidermal Model EpiDerm™ (EPI-200-SIT). MK-24-007-0023. Available at https://www.mattek.com/wp-content/uploads/Medical-Devices-Testing-Protocol-201603010.pdfhttps://www.mattek.com/wp-content/uploads/EPI-200-SIT-Skin-Irritation_MK-24-007-0023_10_02_19.pdf, 2017 | |
[22] | Nomura Y., Lee M., Fukui C., Watanabe K., Olsen D., Turley A., Morishita Y., Kawakami T., Yuba T., Fujimaki H., Inoue K., Yoshida M., Ogawa K., & Haishima Y. Proof of concept testing of a positive reference material for in vivo and in vitro skin irritation testing. J Biomed Mater Res B Appl Biomater, 2018, 106(8) pp. 2807–2814 | |
[23] | Scott L., Eskes C., Hoffmann S., Adriaens E., Alepée N., Bufo M., & et al A proposed eye irritation testing strategy to reduce and replace in vivo studies using Bottom-Up and Top-Down approaches. Toxicol. In Vitro. 2010, 24 pp. 1–9 | |
[24] | Wahlberg J.E., & Wahlberg E.N. Quantification of skin blood flow at patch test sites. Contact Dermat. 1987, 17 pp. 229–233 | |
[25] | Wahlberg J.E., & Mailbach H.I. Nonanoic acid irritation — A positive control at routine patch testing? Contact Dermat. 1980, 6 pp. 128–130 | |
[26] | Walters R.M., Khanna P., Hamilton M., Mays D.A., & Telofski L. Human Cumulative Irritation Tests of Common Preservatives Used in Personal Care Products: A Retrospective Analysis of Over 45 000 Subjects. Toxicol. Sci. 2015, 148 pp. 101–107 | |
[27] | York M., Griffiths H.A., Whittle E., & et al Evaluation of a human patch test for the identification and classification of skin irritation potential, Contact Dermatitis, 1996, 34, pp. 204–212. | |
[28] | European Chemical Industry Ecology and Toxicology Centre Eye irritation testing, Monograph 11, Brussels, Belgium, 1988 | |
[29] | Organization for Economic Cooperation and Development (OECD) Guidelines for testing of chemicals No. 405, Acute eye irritation/corrosion. OECD Publications, Paris, 2017 | |
[30] | Organization for Economic Cooperation and Development (OECD) Guidelines for testing of chemicals. No. 430, In Vitro Skin Corrosion: Transcutaneous Electrical Resistance Test (TER). OECD Publications, Paris, 2015 | |
[31] | Organization for Economic Cooperation and Development (OECD) Test No. 431: In vitro skin corrosion: reconstructed human epidermis (RHE) test method, OECD Guidelines for the Testing of Chemicals, Section 4, Éditions OCDE, Paris, 2019 | |
[32] | Organization for Economic Cooperation and Development (OECD) Guidelines for testing of chemicals. No. 437. Bovine Corneal Opacity and Permeability Test Method for Identifying i) Chemicals Inducing Serious Eye Damage and ii) Chemicals Not Requiring Classification for Eye Irritation or Serious Eye Damage. OECD Publications, 2020 | |
[33] | Organization for Economic Cooperation and Development (OECD) Test No. 438: Isolated Chicken Eye Test Method for Identifying i) Chemicals Inducing Serious Eye Damage and ii) Chemicals Not Requiring Classification for Eye Irritation or Serious Eye Damage, OECD Guidelines for the Testing of Chemicals, Section 4, Éditions OCDE, Paris, 2018 | |
[34] | Organization for Economic Cooperation and Development (OECD) Guidelines for testing of chemicals. No. 460. Fluorescein Leakage Test Method for Identifying Ocular Corrosives and Severe Irritants. OECD Publications, Paris, 2017 | |
[35] | Organization for Economic Cooperation and Development (OECD) Test No. 491: Short Time Exposure In Vitro Test Method for Identifying i) Chemicals Inducing Serious Eye Damage and ii) Chemicals Not Requiring Classification for Eye Irritation or Serious Eye Damage, OECD Guidelines for the Testing of Chemicals, Section 4, Éditions OCDE, Paris, 2020. | |
[36] | Organization for Economic Cooperation and Development (OECD) Test No. 492: Reconstructed human Cornea-like Epithelium (RhCE) test method for identifying chemicals not requiring classification and labelling for eye irritation or serious eye damage, OECD Guidelines for the Testing of Chemicals, Section 4, Éditions OCDE, Paris, 2019 | |
[37] | Organization for Economic Cooperation and Development (OECD) Guidance Document on the Validation and International Acceptance of New or Updated Test Methods for Hazard Assessment, OECD Series on Testing and Assessment, No. 34, OECD Publishing, Paris, 2005 | |
[38] | British Pharmacopoeia Commission. British Pharmacopoeia 2016. London: TSO; 2016. | |
[39] | European Pharmacopoeia , 10th Edition , European Pharmacopoeia, Council of Europe, B.P. 907, F-67029 Strasbourg, France, 2019 | |
[40] | United States Pharmacopeia and National Formulary (USP 43-NF 38). Rockville, MD: United States Pharmacopeial Convention; 2020. | |
[41] | Commission Regulation (EU) 2019/1390 of 31 July 2019 amending, for the purpose of its adaptation to technical progress, the Annex to Regulation (EC) No 440/2008 laying down test methods pursuant to Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (Text with EEA relevance) OJ L 247, 26.9.2019 |
ICS 11.100.20 Price based on 60 pages
© ISO 2021All rights reserved
| iso.org |